The global liquid biopsy market is projected to experience remarkable growth, with an estimated revenue of USD 1,538.3 million in 2023. Driven by rapid advancements in diagnostic technology and an increasing prevalence of cancer, the market is expected to expand at a robust compound annual growth rate (CAGR) of 21.7% over the next decade. By …